China Medical Technologies, Inc(NasdaqGS: CMED )
Pre-Market Real-Time: 5.33 0.40 (8.11%)
China Medical Technologies Inc.’s /quotes/zigman/97818/quotes/nls/cmed CMED
+9.33% U.S.-listed shares gained 8.5% after the Beijing-based maker of
diagnostic systems said that China’s State Food and Drug Administration had
approved its test related to the use of a drug for the treatment of
colorectal cancer.